- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01356095
A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi
Despite increased emphasis on evidence based practice in recent years a gap remains between evidence and practice, particularly in resource poor countries. Few studies to date have examined the use of knowledge translation strategies to improve health care outcomes in low income countries. However, given that the majority of health care in these settings is provided by workers with less training and limited resources, the theoretical potential for knowledge translation strategies to improve health care delivery and outcomes by integrating best evidence into routine practice may be greatest in these settings.
Knowledge translation (KT) is an approach to changing health care provider behavior to reduce the gap between evidence and practice in health care delivery. There has been a tendency for knowledge translation interventions to employ generic, "off the shelf", strategies, and apply them to deal with specific issues. This generic approach, fails to recognize the variability in the specific characteristics of health care settings, in terms of their patient populations, health care systems, and health care providers. These characteristics, whether they function as barriers or facilitators to change, make a generalized approach to KT ineffective, where a tailored strategy, which specifically adjusts its approach to measured local barriers and facilitators may achieve better alignment of practice to evidence. This is likely to be particularly true in low income countries where the majority of health care is provided by non-physician health care workers, working within a wider range of health care systems, with variable and unique patient populations and resource constraints. Given the potential to significantly impact health care outcomes at relatively low cost, further research is needed both to develop methods for identifying potential barriers and facilitators to KT strategies in specific resource poor settings, and to evaluate the effectiveness of KT strategies tailored to address the identified barriers.
This study will assess the effectiveness of a two part knowledge translation intervention tailored to address factors identified in a previous study as functioning as barriers and facilitators to treatment adherence among patients on treatment for tuberculosis or combined tuberculosis and antiretroviral treatment, targeting improved patient adherence and health outcomes, in a specific low income country.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zomba, Malawi
- Zomba District Health Centers, Dignitas International
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All health centers in Zomba District
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Active Comparator: PALM-Plus control
Health centers randomized to Palm-Plus intervention in larger trial this trial is embedded in, but not receiving the adherence intervention.
|
Clinical guideline and training approach, designed for mid-level healthworkers.
|
|
Experimental: Adherence intervention
Intervention arm.
|
Two part intervention includes an educational outreach intervention for health care workers and a point of care patient education/counselling tool, delivered to providers within health centers randomized to the intervention arm, using a train the trainer on-site training model.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients classified as successfully treated.
Time Frame: 1 year
|
Treatment success is defined as cure or treatment completion.
Outcomes measured at patient level at end of treatment (6 months), and at 1 year at health center level (randomized at level of health center)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients defaulting from treatment.
Time Frame: 1 year
|
Default defined as missing greater than or equal 2 consecutive months of treatment.
Outcome measured at patient level at end of treatment (6 months), and 1 year at level of health center (randomized at level of health center).
|
1 year
|
|
Proportion of successfully treated and default cases among patients treated for tuberculosis only and those on both tuberculosis and antiretroviral treatment
Time Frame: 1 year
|
Treatment success defined as cure or treatment completion.
Outcome measured at patient level at end of treatment (6 months), and at 1 year for the the health center (randomized at level of health center)
|
1 year
|
|
Weight change.
Time Frame: 1 year
|
Weight change from start to end of treatment.
Outcome measured at patient level throughout treatment (6 months) and at 1 year at the health center level (randomized at level of health center).
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lisa Puchalski Ritchie, University of Toronto
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DI807
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tuberculosis
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Beijing Chest HospitalHuashan Hospital; National Medical Center for Infectious DiseasesNot yet recruitingTuberculosis | Drug-resistant Tuberculosis | Pulmonary Tuberculosis | Rifampicin Resistant TuberculosisChina
-
Universiteit AntwerpenAurum Institute; University of Stellenbosch; University of the Free State; Free...RecruitingDrug-resistant Tuberculosis | Rifampicin Resistant Tuberculosis | Pulmonary Tuberculoses | Multidrug Resistant TuberculosisSouth Africa
-
Assistance Publique - Hôpitaux de ParisCompletedExtrapulmonary Tuberculosis | Lymph Node Tuberculosis | Bone TuberculosisFrance
-
Centers for Disease Control and PreventionBoston University; Pfizer; Columbia University; University of Texas; University of... and other collaboratorsCompletedMulti-Drug Resistant Tuberculosis | Extensively Drug Resistant TuberculosisSouth Africa
-
University of Cape TownUniversity of Stellenbosch; University of Cape Town Lung Institute; University... and other collaboratorsCompletedTuberculosis | Multidrug Resistant Tuberculosis | Extensively-drug Resistant TuberculosisSouth Africa
-
Huashan HospitalThe Hong Kong Polytechnic UniversityNot yet recruitingPulmonary Tuberculosis | Tuberculosis (TB) | Tuberculosis ActiveChina
-
Shandong UniversityShandong Public Health Clinical CenterNot yet recruiting
-
Huashan HospitalBeijing Chest HospitalActive, not recruitingDrug-resistant Tuberculosis | Pulmonary Tuberculosis | Rifampin-resistant TuberculosisChina
Clinical Trials on Palm-Plus
-
Sakarya UniversityCompletedPain | Injection | Fear | Preschool Age ChildrenTurkey (Türkiye)
-
North Suffolk Mental Health AssociationUnknown
-
Sakarya UniversitySakarya University Education and Research HospitalCompletedTo Compare the Effect of Two Different Nonpharmacological Methods on Pain and Fear During Peripheral Intravenous CatheterizationTurkey
-
Malaysia Palm Oil BoardIMU University, MalaysiaActive, not recruiting
-
Universiti Kebangsaan Malaysia Medical CentreMalaysia Palm Oil Board; Hovid BerhadNot yet recruitingAlcoholic Fatty Liver DiseaseMalaysia
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
-
Malaysia Palm Oil BoardUnknown
-
Universiti Sains MalaysiaClinical Research Centre, Malaysia; Malaysia Palm Oil BoardWithdrawnPrediabetesMalaysia
-
Imperial College LondonMalaysia Palm Oil BoardCompletedHealthy VolunteersUnited Kingdom